May 8, 2024
The University of Cincinnati's Vince Martin spoke with South Bend television station WNDU on a recent study that found people who suffer from migraines might be able to predict when one is coming hours before symptoms even start.
May 9, 2024
Memphis, Tennessee television station Action News 5 featured research from the University of Cincinnati's Laura Ngwenya and Jed Hartings that is testing the first treatments for spreading depolarizations, abnormal brain activity also called a "brain tsunami."
May 2, 2024
The University of Cincinnati's Vincent Martin was featured in a New York Magazine/The Cut article discussing the lack of solid evidence that chocolate is a migraine trigger.
March 24, 2022
The University of Cincinnati is enrolling patients for a new clinical trial testing a two-pronged immunotherapy approach to treat glioblastomas, deadly brain tumors.
January 20, 2022
University of Cincinnati researcher physicians are hosting the BEAT-MS trial which will study the effectiveness of stem cell transplant compared to the currently best available treatments for multiple sclerosis.
January 13, 2022
University of Cincinnati researchers have received a U.S. Department of Defense grant to further study how stress hormone receptors affect brain cell degeneration in Parkinson's disease.
April 16, 2021
Hani Kushlaf, MD, presented findings on a new treatment for Pompe disease, a rare neuromuscular disease, virtually at the American Academy of Neurology on April 17.
June 28, 2021
A study, led by the University of Cincinnati, sheds new light on Alzheimer's disease and a highly debated new drug therapy.
March 28, 2022
The University of Cincinnati's Daniel Woo and colleagues recently published a paper in JAMA revealing new insights on how different risk factors following intracerebral hemorrhages can affect patient outcomes.
May 24, 2022
The University of Cincinnati's College of Medicine and College-Conservatory of Music collaborate on the innovative Dementia and the Arts course and intervention for community members with cognitive disorders and their family members.